BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 20817924)

  • 21. Inherited skin disorders presenting with poikiloderma.
    Rayinda T; van Steensel M; Danarti R
    Int J Dermatol; 2021 Nov; 60(11):1343-1353. PubMed ID: 33739439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dyskeratosis congenita as a disorder of telomere maintenance.
    Nelson ND; Bertuch AA
    Mutat Res; 2012 Feb; 730(1-2):43-51. PubMed ID: 21745483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poikiloderma with neutropenia, Clericuzio type, in a family from Morocco.
    Mostefai R; Morice-Picard F; Boralevi F; Sautarel M; Lacombe D; Stasia MJ; McGrath J; Taïeb A
    Am J Med Genet A; 2008 Nov; 146A(21):2762-9. PubMed ID: 18925663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between DNA methylation and telomere length in dyskeratosis congenita.
    Gadalla SM; Katki HA; Shebl FM; Giri N; Alter BP; Savage SA
    Aging Cell; 2012 Feb; 11(1):24-8. PubMed ID: 21981348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Marked overlap of four genetic syndromes with dyskeratosis congenita confounds clinical diagnosis.
    Walne AJ; Collopy L; Cardoso S; Ellison A; Plagnol V; Albayrak C; Albayrak D; Kilic SS; Patıroglu T; Akar H; Godfrey K; Carter T; Marafie M; Vora A; Sundin M; Vulliamy T; Tummala H; Dokal I
    Haematologica; 2016 Oct; 101(10):1180-1189. PubMed ID: 27612988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita.
    Vulliamy T; Beswick R; Kirwan M; Marrone A; Digweed M; Walne A; Dokal I
    Proc Natl Acad Sci U S A; 2008 Jun; 105(23):8073-8. PubMed ID: 18523010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Germline mutations of regulator of telomere elongation helicase 1, RTEL1, in Dyskeratosis congenita.
    Ballew BJ; Yeager M; Jacobs K; Giri N; Boland J; Burdett L; Alter BP; Savage SA
    Hum Genet; 2013 Apr; 132(4):473-80. PubMed ID: 23329068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita.
    Alter BP; Baerlocher GM; Savage SA; Chanock SJ; Weksler BB; Willner JP; Peters JA; Giri N; Lansdorp PM
    Blood; 2007 Sep; 110(5):1439-47. PubMed ID: 17468339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dyskeratosis congenita with a novel genetic variant in the DKC1 gene: a case report.
    Ratnasamy V; Navaneethakrishnan S; Sirisena ND; Grüning NM; Brandau O; Thirunavukarasu K; Dagnall CL; McReynolds LJ; Savage SA; Dissanayake VHW
    BMC Med Genet; 2018 May; 19(1):85. PubMed ID: 29801475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dyskeratosis congenita -- a disease of dysfunctional telomere maintenance.
    Mason PJ; Wilson DB; Bessler M
    Curr Mol Med; 2005 Mar; 5(2):159-70. PubMed ID: 15974869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A unique homozygous WRAP53 Arg298Trp mutation underlies dyskeratosis congenita in a Chinese Han family.
    Shao Y; Feng S; Huang J; Huo J; You Y; Zheng Y
    BMC Med Genet; 2018 Mar; 19(1):40. PubMed ID: 29514627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita.
    Savage SA; Giri N; Baerlocher GM; Orr N; Lansdorp PM; Alter BP
    Am J Hum Genet; 2008 Feb; 82(2):501-9. PubMed ID: 18252230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation.
    Vulliamy TJ; Marrone A; Knight SW; Walne A; Mason PJ; Dokal I
    Blood; 2006 Apr; 107(7):2680-5. PubMed ID: 16332973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dyskeratosis congenita: telomerase, telomeres and anticipation.
    Marrone A; Walne A; Dokal I
    Curr Opin Genet Dev; 2005 Jun; 15(3):249-57. PubMed ID: 15917199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CTC1 Mutations in a patient with dyskeratosis congenita.
    Keller RB; Gagne KE; Usmani GN; Asdourian GK; Williams DA; Hofmann I; Agarwal S
    Pediatr Blood Cancer; 2012 Aug; 59(2):311-4. PubMed ID: 22532422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders.
    Ballew BJ; Savage SA
    Expert Rev Hematol; 2013 Jun; 6(3):327-37. PubMed ID: 23782086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dyskeratosis congenita: a disorder of defective telomere maintenance?
    Walne AJ; Marrone A; Dokal I
    Int J Hematol; 2005 Oct; 82(3):184-9. PubMed ID: 16207588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telomerase RNA mutated in autosomal dyskeratosis congenita reconstitutes a weakly active telomerase enzyme defective in telomere elongation.
    Cerone MA; Ward RJ; Londoño-Vallejo JA; Autexier C
    Cell Cycle; 2005 Apr; 4(4):585-9. PubMed ID: 15753647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clericuzio type poikiloderma with neutropenia is distinct from Rothmund-Thomson syndrome.
    Van Hove JL; Jaeken J; Proesmans M; Boeck KD; Minner K; Matthijs G; Verbeken E; Demunter A; Boogaerts M
    Am J Med Genet A; 2005 Jan; 132A(2):152-8. PubMed ID: 15558713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequence analysis of the shelterin telomere protection complex genes in dyskeratosis congenita.
    Savage SA; Giri N; Jessop L; Pike K; Plona T; Burdett L; Alter BP
    J Med Genet; 2011 Apr; 48(4):285-8. PubMed ID: 21209122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.